Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with CirrhosisNagisa Hara, Yoshiyuki Takei, Yoshinao Kobayashi et al.|Internal Medicine|2016Cited by 114
The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)Yoshinao Kobayashi, Osamu Taguchi, Nagisa Hara et al.|Internal Medicine|2017Cited by 58
Changes in liver function and body composition by direct‐acting antiviral therapy for hepatitis C virus infectionRyosuke Sugimoto, Yoshiyuki Takei, Motoh Iwasa et al.|Hepatology Research|2017Cited by 31
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Yoshiyuki Takei, Ryosuke Sugimoto et al.|Metabolic Brain Disease|2016Cited by 28